You're on a GLP-1 drug. Your appetite is down. That's the point — it's working.
But there's a problem nobody warned you about: when you eat 30-40% less food, your nutrient intake drops by the same amount. Your medication is managing your appetite. Nothing is managing the nutrition gap it creates.
The Hidden Cost of Eating Less
GLP-1 medications — Ozempic, Wegovy, Zepbound, Mounjaro — work by slowing gastric emptying, reducing appetite, and lowering blood sugar. For weight management, they're remarkably effective.
But reduced appetite means reduced food volume. And reduced food volume means reduced nutrient intake across the board.
The research is sobering:
- A retrospective study published in Obesity Pillars found over 20% of GLP-1 users develop nutritional deficiencies within a year [1]
- Skeletal muscle loss of 10%+ in major trials — equivalent to roughly 20 years of age-related muscle atrophy, according to the landmark STEP 1 trial published in the New England Journal of Medicine [2]
- Common deficiencies include vitamins A, B12, D, E, iron, and zinc [1]
- GI side effects (nausea, constipation) affect up to 44% of users, further reducing what people can comfortably eat [3]
This isn't a reason to stop your medication. It's a reason to completely rethink what you eat with the smaller appetite you have.
Nutrient density per calorie becomes the single most important metric in your diet.
The Thylakoid Discovery: Your Greens Are Already Making GLP-1
Here's what most people — including most doctors — don't know yet.
Thylakoids are membrane structures found in the chloroplasts of green leafy vegetables. They're the part of the plant cell where photosynthesis happens. And when you eat them, something remarkable occurs.
A systematic review published in the Journal of Diabetes & Metabolic Disorders covering all 8 randomized controlled trials on thylakoids found appetite reduction across every single study [4]. Lund University research published in Appetite documented a 95% reduction in hedonic hunger — that's cravings, the "I want it" hunger rather than the "I need it" hunger [5]. Thylakoid groups lost 43% more weight than control groups [5]. Thylakoids also lowered triglycerides and increased beneficial gut bacteria [4][5].
The mechanism: thylakoids slow fat digestion in the gut, which triggers natural GLP-1 release from intestinal L-cells — the same pathway your medication targets [4].
The leafy greens you should already be eating for their nutrient density also contain compounds that naturally stimulate GLP-1 production through a complementary, food-based mechanism.
Your greens aren't just supporting your GLP-1 therapy. They're amplifying it.
This is not a replacement for your medication. It's a natural ally that works alongside it.
What This Means for Your Diet
When every calorie has to earn its place, leafy greens are the highest-return investment you can make. They deliver the most nutrients per calorie of any food group, and they contain thylakoids that support the same hormonal pathway your medication uses.
The challenge is practical: on days when your appetite is minimal and nausea makes solid food difficult, eating a large salad isn't realistic.
That's where format matters. SaladPower delivers a full serving of organic spinach, kale, and broccoli — plus carrot, apple, and lemon — in 90 calories. It's liquid, so it bypasses the "I can't eat" barrier. It requires no prep, no refrigeration, and no cleanup. And because it's made from real whole-leaf greens (not powder or extract), the thylakoids are intact.
For GLP-1 users specifically: 90 calories of real vegetable nutrition that supports the same pathway your medication targets, in a format designed for low-appetite days. That's what nutrient density per calorie looks like in practice.
What to Do Next
If you're on a GLP-1 medication, three immediate steps:
- Audit your current diet for nutrient density. How many of your daily calories deliver actual vitamins, minerals, and fiber versus empty energy? On a reduced calorie budget, every gap compounds.
- Prioritize leafy greens daily. Not because they're trendy — because the research on thylakoids and GLP-1 support is strong, and the nutrient density is unmatched.
- Talk to your doctor about monitoring. Ask specifically about vitamins A, B12, D, iron, zinc, and folate. Deficiencies develop gradually — catching them early is straightforward. Reversing them later is harder.
Read our companion post, How to Eat Smarter on a GLP-1 Drug, for a complete daily nutrition framework, deficiency monitoring guide, and practical strategies for low-appetite days.
Frequently Asked Questions
Can leafy greens really support GLP-1 production?
Yes. Thylakoids — membrane structures in leafy green chloroplasts — slow fat digestion and trigger natural GLP-1 release from intestinal L-cells. This has been demonstrated across all 8 randomized controlled trials in the published systematic review [4]. It's a complementary mechanism to GLP-1 medications, not a replacement.
Why am I losing muscle on Ozempic or Wegovy?
GLP-1 drugs reduce appetite indiscriminately — your body doesn't selectively lose only fat. In the STEP 1 trial published in the New England Journal of Medicine, participants lost 10%+ of their lean muscle mass alongside fat [2]. Adequate protein intake (1.0-1.2g per kg body weight) and resistance exercise are the primary countermeasures [6].
What nutrients should I monitor on a GLP-1 drug?
The most common deficiencies in GLP-1 users include vitamins A, B12, D, E, iron, zinc, and folate [1]. Ask your prescribing doctor about baseline testing and periodic monitoring — especially if you've been on medication for more than six months.
Is SaladPower good for people on GLP-1 medications?
SaladPower delivers 90 calories of organic whole-food greens with 5g fiber, 2g protein, and intact thylakoids that support natural GLP-1 production. The liquid format makes it easy to consume on low-appetite days, and the nutrient density per calorie is exactly what a reduced-intake diet requires.
Sources
- Butsch WS, Sulo S, Chang AT, et al. "Nutritional deficiencies in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study." Obesity Pillars. 2025;15:100186. doi.org
- Wilding JPH, Batterham RL, Calanna S, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity" (STEP 1 Trial). New England Journal of Medicine. 2021;384:989-1002. doi.org
- Wegovy (semaglutide 2.4 mg) Prescribing Information. U.S. Food and Drug Administration. 2023. accessdata.fda.gov
- Amirinejad A, Heshmati J, Shidfar F. "Effects of thylakoid intake on appetite and weight loss: a systematic review." Journal of Diabetes & Metabolic Disorders. 2020;19:565-573. doi.org
- Montelius C, Erlandsson D, Vitija E, et al. "Body weight loss, reduced urge for palatable food and increased release of GLP-1 through daily supplementation with green-plant membranes for three months in overweight women." Appetite. 2014;81:295-304. doi.org
- Mozaffarian D, Agarwal M, Aggarwal M, et al. "Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from ACLM, ASN, OMA, and TOS." American Journal of Clinical Nutrition. 2025. doi.org
This article is for informational purposes only and is not a substitute for medical advice. Always consult your prescribing physician before making dietary changes while on GLP-1 medication.